Amdocs (NASDAQ:DOX – Get Free Report) updated its first quarter 2026 earnings guidance on Tuesday. The company provided EPS guidance of 1.730-1.790 for the period, compared to the consensus EPS estimate of 1.780. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion. Amdocs also updated its FY 2026 guidance to 7.270-7.550 EPS.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on DOX shares. Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research note on Thursday, October 30th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $108.00.
Check Out Our Latest Analysis on DOX
Amdocs Stock Performance
Amdocs Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be given a dividend of $0.527 per share. The ex-dividend date is Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a yield of 2.5%. Amdocs’s payout ratio is 42.60%.
Institutional Investors Weigh In On Amdocs
Institutional investors have recently made changes to their positions in the company. Geneos Wealth Management Inc. boosted its stake in shares of Amdocs by 213.9% during the 1st quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company’s stock worth $64,000 after purchasing an additional 477 shares during the period. Merit Financial Group LLC raised its position in Amdocs by 12.0% in the 3rd quarter. Merit Financial Group LLC now owns 6,533 shares of the technology company’s stock worth $536,000 after purchasing an additional 700 shares during the period. Man Group plc raised its position in Amdocs by 3.0% in the 2nd quarter. Man Group plc now owns 25,814 shares of the technology company’s stock worth $2,355,000 after purchasing an additional 760 shares during the period. EverSource Wealth Advisors LLC lifted its stake in Amdocs by 140.9% in the second quarter. EverSource Wealth Advisors LLC now owns 1,660 shares of the technology company’s stock worth $151,000 after purchasing an additional 971 shares during the last quarter. Finally, Empowered Funds LLC boosted its position in shares of Amdocs by 12.0% during the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock valued at $1,462,000 after buying an additional 1,709 shares during the period. Institutional investors own 92.02% of the company’s stock.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- 3 Fintech Stocks With Good 2021 Prospects
- Amazon Is One of the Clearest Buys If the Market Dips Again
- Stock Market Sectors: What Are They and How Many Are There?Â
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
